thyssenkrupp nucera AG & Co. KGaA (NCH2) short interest & options flow
XTRANCH2 closed Thursday at €7.96, up just over 1% on the week — a modest stabilisation that masks a borrow market still running at extreme stress, even as the most acute pressure begins, very slightly, to abate. The clearest shift since the previous two notes is in availability, which has moved from 7% to just under 10%. That sounds like relief. It isn't. One share available for…
NCH2 utilization hits 91.58%, near its 52-week high of 100%, as availability plummets to just 3.1% — indicating acute scarcity of borrowable shares and extreme difficulty for short sellers to source stock.
- Market cap
- $1.09B
- Next earnings
- 16 Dec 2026
Key data as of 8 Nov 2026
Latest signals on NCH2
- Utilization
NCH2 utilization hits 91.58%, near its 52-week high of 100%, as availability plummets to just 3.1% — indicating acute scarcity of borrowable shares and extreme difficulty for short sellers to source stock.
- Cost to Borrow
NCH2 cost to borrow surges to 142.3%, up 121.5% in one week amid near-total borrow scarcity on Xetra.
NCH2 news and analysis
RSSNo long-form analysis yet for NCH2. Pulse alerts and the live data picture are available on ORTEX.
Open NCH2 on ORTEX →Want the live picture for NCH2?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NCH2 — free to start on ORTEX.
Sign up for free →Open NCH2 on ORTEX